1 dose: 3 days is within one re-dosing interval.
Show every combination
The tables show the whole wells one vial gives at each concentration, one treatment each. Sizes above 100 nmol are sold by quotation.
| Size | 5 μM | 10 μM | 20 μM |
|---|---|---|---|
| 10 nmol | 20 | 10 | 5 |
| 25 nmol | 50 | 25 | 12 |
| 50 nmol | 100 | 50 | 25 |
| 100 nmol | 200 | 100 | 50 |
| Size | 5 μM | 10 μM | 20 μM |
|---|---|---|---|
| 10 nmol | 8 | 4 | 2 |
| 25 nmol | 20 | 10 | 5 |
| 50 nmol | 40 | 20 | 10 |
| 100 nmol | 80 | 40 | 20 |
| Size | 5 μM | 10 μM | 20 μM |
|---|---|---|---|
| 10 nmol | 4 | 2 | 1 |
| 25 nmol | 10 | 5 | 2 |
| 50 nmol | 20 | 10 | 5 |
| 100 nmol (the size to order) | 40 | 20 | 10 |
| Size | 5 μM | 10 μM | 20 μM |
|---|---|---|---|
| 10 nmol | 2 | 1 | 0 |
| 25 nmol | 5 | 2 | 1 |
| 50 nmol | 10 | 5 | 2 |
| 100 nmol | 20 | 10 | 5 |
| Size | 5 μM | 10 μM | 20 μM |
|---|---|---|---|
| 10 nmol | 1 | 0 | 0 |
| 25 nmol | 2 | 1 | 0 |
| 50 nmol | 5 | 2 | 1 |
| 100 nmol | 10 | 5 | 2 |
Adjust the wells
Multiplies the wells per sequence.
Multiplies the wells per sequence.
The 24-well plate holds 500 μL.
Show the dilution
The working solution at 10 μM from the 1 mM stock, in complete medium.
For a single well:
Step 01
Add stock solution
5 μL
of the 1 mM stock
Step 02
Add buffer
495 μL
complete medium
Step 03
Final solution
10 μM
500 μL (1:100 dilution)
For 10 wells (with 20% excess):
Mix 60 μL stock + 5,940 μL buffer = 6 mL of working solution
In the same well, 2.5 μL of stock makes 5 μM and 10 μL of stock makes 20 μM.
Compare the products
| Feature | sdASO | toASO |
|---|---|---|
| Transfection required | No | Yes |
| Typical concentration | 5-20 μM | 50-100 nM |
Guidelines sdASO and toASO
ASO usage guide
sdASO
AUMsilence sdASO guidelines
Getting started
The same range for every cell type
From primary neurons and cardiomyocytes to immortalized lines and fast-dividing cancer lines, the range above is the one to work in. Where inside it a particular line lands is what the first experiment tells you.
Protocol overview
- 01Reconstitute lyophilized ASO to 1 mM in nuclease-free water
- 02Aliquot and store at -20°C or -80°C
- 03Dilute to working concentration (5-20 μM) in complete media
- 04Add directly to cells: no transfection reagent needed
- 05Incubate for 24-72 hours
- 06Assess knockdown efficiency by qRT-PCR or Western blot
Key advantages
- No transfection reagent required
- Reduced toxicity compared to transfection
- Works in serum-containing media
- Suitable for difficult-to-transfect cells
Optimization strategy
- 01Start at 10 μM
- 02Assess knockdown at 24-72 hours post-treatment
- 03If knockdown is poor: move up towards 20 μM
If knockdown is strong: move down towards 5 μM
toASO
AUMsilence toASO guidelines
Working concentration
Final working concentration: 50-100 nM
This range holds for every transfection method.
Transfection methods
| Method | Key features | Best for |
|---|---|---|
| Lipid-based | Most common, gentle | Most adherent cell lines |
| Electroporation | High efficiency, no reagent | Primary cells, suspension cells |
| Calcium phosphate | Cost-effective | Some adherent cells |
| Polymer-based | Low toxicity | Sensitive cells |
Lipid transfection protocol
- 01Prepare cells at 50-70% confluency
- 02Dilute toASO in serum-free medium
- 03Dilute transfection reagent separately
- 04Combine and incubate 5-20 min
- 05Add complex to cells
- 06Assess knockdown at 24-72h post-transfection
Troubleshooting guide
Low knockdown?
- Move up within 50 nM to 100 nM
- Optimize ASO:reagent ratio
- Try a different transfection method
High toxicity?
- Reduce concentration toward 50 nM, the bottom of the range
- Decrease transfection reagent
- Shorten incubation time
Coverage calculator
Number of wells per product size (96-well plate at 50 nM, 120 μL in the well with the two dilutions):
- 2 nmol = 333 wells
- 5 nmol = 833 wells
- 10 nmol = 1,666 wells
- 25 nmol = 4,166 wells
Actual coverage depends on confluency, controls, and safety margins.
Both products
General best practices
Storage & stock preparation
- Store lyophilized ASOs at -20°C (stable for years)
- sdASO Standard stock: 1 mM
- What the protocol tables are worked from: 1% of a well's volume at 10 μM, a minimal addition to the cells
- toASO Working stock: 2 μM
- Pre-diluted for direct use in transfection
- Minimizes pipetting errors
- Aliquot to avoid freeze-thaw cycles (≤3 cycles)
- Store aliquots: -20°C (1 month) or -80°C (6 months)
- Working solutions stable 48h at 4°C
Experimental controls
- Negative control: Scrambled sequence ASO
- Positive control: Validated ASO (e.g., GAPDH)
- Mock control: Transfection reagent only
- Untreated control: Cells with media only
Validation methods
- qRT-PCR: The most commonly used method for mRNA quantification
- Western blot: Confirmation of protein knockdown
- Flow cytometry: Cell surface proteins
- Immunofluorescence: Protein levels
Timeline considerations
- mRNA knockdown: 24-72 hours
- Protein knockdown: 48-96 hours
- Phenotypic changes: 72+ hours
- Re-dosing: Every 3 to 5 days if needed
For research use only. Not for use in diagnostic or therapeutic procedures.